GeneralBullishBlockonomi · 4h ago6/10
📰
Novo Nordisk (NVO) Stock Surges 6.55% on Oral Wegovy UK Approval
Novo Nordisk's stock climbed 6.55% following UK regulatory approval of an oral formulation of Wegovy, its popular weight-loss medication. The approval marks a significant milestone for the pharmaceutical company, expanding the drug's accessibility beyond injectable forms and supporting a broader European research initiative.